| Entry |
|
|---|
| Name |
Endralazine mesylate (USAN);
Endralazine monomethanesulfonate;
Migranal (TN) |
|---|
| Formula |
C14H15N5O. CH4SO3
|
|---|
| Exact mass |
365.1158
|
|---|
| Mol weight |
365.4075
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG02046 Hydrazinophthalazine derivative
|
|---|
| Remark |
|
|---|
| Efficacy |
Antihypertensive |
|---|
| Comment |
Hydrazinophthalazine derivative
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON
C02DB Hydrazinophthalazine derivatives
C02DB03 Endralazine
D03994 Endralazine mesylate (USAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG02046 Hydrazinophthalazine derivative
DG00262 Endralazine
D03994 Endralazine mesylate
Drug groups [BR:br08330]
Cardiovascular agent
DG02046 Hydrazinophthalazine derivative
DG00262 Endralazine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 25
1 C8x C 3.9900 -13.5100
2 C8x C 3.9900 -14.9100
3 C8x C 5.2024 -15.6100
4 C8x C 6.4149 -14.9100
5 C8y C 6.4149 -13.5100
6 C8x C 5.2024 -12.8100
7 C1x C 8.8397 -14.9100
8 N1y N 8.8397 -13.5100
9 C5a C 7.6273 -12.8100
10 C1x C 10.0522 -15.6100
11 C8y C 11.2646 -14.9100
12 C8y C 11.2646 -13.5100
13 C1x C 10.0522 -12.8100
14 O5a O 7.6273 -11.4100
15 N5x N 12.4770 -15.6100
16 N4x N 13.6895 -14.9100
17 C8y C 13.6895 -13.5100
18 C8x C 12.4770 -12.8100
19 N2b N 14.9246 -12.7966
20 N1a N 16.1319 -13.4934
21 S4a S 21.6278 -14.3023
22 C1a C 20.2279 -14.3023
23 O1d O 23.0277 -14.3023
24 O1d O 21.6278 -12.9024
25 O1d O 21.6278 -15.7023
BOND 26
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 7 8 1
8 8 9 1
9 5 9 1
10 7 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 8 13 1
15 9 14 2
16 11 15 2
17 15 16 1
18 16 17 1
19 17 18 1
20 12 18 2
21 17 19 2
22 19 20 1
23 21 22 1
24 21 23 1
25 21 24 2
26 21 25 2
|
|---|
